ORAMED PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $26.2M | $3.9M |
| FY2017 | — | $19.2M | $4.0M |
| FY2018 | $11.4M | $31.1M | $5.0M |
| FY2019 | $9.7M | $19.4M | $3.3M |
| FY2020 | — | $32.9M | $19.3M |
| FY2021 | — | $115.8M | $77.2M |
| FY2022 | $25.0K | $151.8M | $40.5M |
| FY2023 | — | $163.8M | $9.1M |
| FY2024 | — | $146.3M | $54.4M |
| FY2025 | — | $199.7M | $45.9M |